next generation glp 1 drugs GLP-1 are often misunderstood. They are not “celebrity weight loss injections.” They are the result of 40 years of metabolic research and may change how we treat obesity, diabetes, and aging Market Overview: GLP-1 Agonists and
Description
The rejection is expected
What's more, the weight loss didn't significantly slow down even as the trial drew to a close
Every medication has: Benefits Risks Interactions Before administering a drug, always ask: What else is this patient taking
The authors discuss that the duration of treatment, the dose of the GLP-1 agonist, or the age of mice might be responsible for the lack of anti-atherogenic activity in this study
They have developed an antibody (a more complex molecule than a peptide) that antagonizes GIP
